Do patients experience decisional regret after sacral neuromodulation for refractory overactive bladder?

Abstract

AbstractObjectiveSuccess following urological procedures is traditionally defined through objective endpoints. This approach may not capture the impact on patient satisfaction. There is a paucity of literature evaluating patient‐centered metrics such as satisfaction and decisional regret in the field of urology. This study investigates long‐term satisfaction and decisional regret amongst patients who underwent sacral neuromodulation (SNM) for the treatment of refractory overactive bladder (OAB).Materials and MethodsThis study retrospectively reviewed patients who underwent SNM for refractory OAB from 2015 to 2022 at a single institution serving an ethnically diverse and underrepresented community. Demographic data were collected through chart review and surveys conducted via telephone calls. Patient satisfaction and decisional regret was measured with the validated modified SDS‐DRS scale (satisfaction with decision scale‐decision regret scale). Descriptive statistics, Wilcoxan rank sum, and median regression analyses were performed using STATA 15.0 with p < 0.05 as significant.ResultsOut of 191 patients who underwent SNM, 63 were unreachable (wrong number in chart, number not in service, patient did not answer, deceased). Eighty‐nine out of 128 patients reached agreed to participate (70% response rate). The mean time since surgery was 37.3 ±25.2 months. The median satisfaction with decision score was 4.0 (IQR: 3.7−4.7) with a score of 1 correlating with low satisfaction and a score of 5 correlating with high satisfaction. The median decisional regret score was 2.0 (IQR: 1.2−2.9) with a score of 1 correlating with low decisional regret and a score of 5 correlating with strong decisional regret. Ten patients reported complications after surgery, which was significantly associated with lower SDS and higher DRS scores (p < 0.01), and persisted after adjusting for age, body mass index, sex, and comorbidities (SDS β coef: −0.84, 95% CI: −1.5 to 0.15, p = 0.02; DRS β coef: 1.48, 95% CI: 0.55−2.41, p < 0.01).ConclusionsPatients who underwent SNM for refractory OAB overall had low regret and high satisfaction with their decision at an average 3 years of follow‐up. As expected, those who developed postoperative complications had worse scores. The inclusion of patient‐centric outcomes is imperative when determining the success of a surgical procedure and is useful for shared decision‐making when advancing to third‐line therapy for OAB. Longer‐term follow‐up is necessary to assess durability of high satisfaction and low regret over time.